# An Efficient and Facile Synthesis of 1,2,4-Aryl Triazoles and 4-Thiazolidinones Bearing 6-Fluorochroman Nucleus

Authors: Piyush B. Vekariya; Jalpa R. Pandya; Hitendra S. Joshi
Journal: International Scholarly Research Notices
 (2014)

---

## Abstract

A new generation of chroman bearing heterocyclic five membered ring such as 1,2,4-triazoles and thiazolidinones was designed and synthesized. New chroman based nucleus 5-(6-fluorochroman-2-yl)-4-aryl-4H-1,2,4-triazole-3-thiol and 6-fluorochroman-N-(4-oxo-2-arylthiazolidinin-3-yl) chroman-2-carboxamides were synthesized. Aryl triazole compounds4a–4j were synthesized from 6-fluorochroman-2-carbohydrazide2 on reaction with base in methanol and CS2 followed by reaction with substituted aniline. Thiazolidinone compounds5a–5j were synthesized from 6-fluorochroman-2-carbohydrazide2 on reaction with substituted aryl aldehyde and thioglycolic acid.


---

## Body

## 1. Introduction

The design and synthesis of hybrid molecules encompassing two pharmacophores in one molecular scaffold is a well-established approach to the synthesis of more potent drugs with dual activity. With this aspect, 6-fluorochroman-2-carboxylic acid derivatives in connection with thiazolidinone and 1, 2, 4-triazoles were found as a promising target for the current research project. 1, 2, 4-Triazoles and 4-thiazolidinones are the broadly investigated molecules. They have proved to be the most useful framework for biological activities among nitrogen containing five membered heterocycles. Amongst the diverse classes of heterocyclic compounds chroman, a class of oxygen containing heterocycle forms an important part of many pharmacologically active compounds. For example, the chroman ring is a constituent of various bioactive compounds that are sodium channel blocker [1], 5
HT
1
A inhibitor [2], and so forth. Commercially available antihypertensive drugs of chroman repinotan [3], robalzotan [4], and specifically 6-fluorochroman nebivolol [5] are well known. Hence, the synthesis of 6-fluorochroman derivatives is currently of significant interest in organic synthesis.Aryl triazoles comprise various heterocyclic compounds possessing promising biological activity and are found as potential antimicrobial [6, 7] and adenosine A
2
A receptor antagonist [8]. According to the green chemistry approach there are many solvent free reactions of 1, 2, 4-aryl triazoles that have been reported [9, 10].4-Thiazolidinones have been widely explored for their applications in the field of medicine and agriculture [11]. They are also known as promising antimicrobial [12], antiinflammatory [13, 14], antimalerial [15], anticancer [16], tuberculostatic [17], and antiviral agents [18]. Several one-pot multicomponent syntheses of 4-thiazolidinone have been reported [19–21].


## 2. Result and Discussion

The syntheses of triazole and thiazolidinone derivatives have been previously reported by many researchers, and they normally required additional additives and long reaction time. So in this paper, we described an efficient and safe procedure for the synthesis of 4-aryl triazole containing chroman nucleus, using 6-fluorochroman-2-carboxylic acid. 6-Fluorochroman-2-carboxylic acid on esterification with methanol in the presence of concentrated H2SO4 at room temperature gave compound1 (Scheme 1) with good yield which on reaction with hydrazine hydrate (99%) gave compound2. Compound2 on reaction with carbon disulphide in the presence of KOH in methanol at RT afforded compound3. This on further reaction with substituted aniline without use of any solvent in fused condition yielded compounds4a–4j (Scheme 1). 1H and 13C NMR spectra of the products clearly indicated the formation of triazoles4a–4j in 75–95% yields (Table 1). The formation of thiol group –SH was identified by a sharp singlet at around δ
=
11
.
43 ppm. By the 13C NMR spectrum also supported the presence of –SH group from the deshielding value of carbon attached to –SH group at δ 168.71 ppm.Table 1
Physical data for4a–4j.
Entry
Substitution R
Yield (%)
4a
4-CH3 phenyl
89
4b
3-Cl phenyl
86
4c
4-F phenyl
78
4d
2,5-Dimethyl phenyl
95
4e
3,4-Dimethyl phenyl
84
4f
2-F phenyl
79
4g
2-Cl phenyl
76
4h
3-Cl-4-F phenyl
87
4i
2-OCH3phenyl
90
4j
2,5-Difluoro phenyl
75Scheme 1
Reaction scheme for the synthesis of4a–4j.Here we introduce the one-pot synthesis of thiazolidinone from hydrazide (Scheme2) with thioglycolic acid, substituted aryl aldehydes in toluene using a Dean-Stark assembly to synthesized compounds5a–5j (Scheme 2). 1H and 13C NMR spectra of the products clearly indicated the formation of 4-thiazolidinone5a–5j in 71–95% yields (Table 2). The formation of –NH group was identified by a sharp singlet at around δ 10.46–10.43 ppm, which is further supported by D2O exchange. 13C NMR spectrum also supported the presence of amide group from the deshielding value of carbon attached to –CONH group at δ 169.3 ppm and carbonyl group (part of a five member ring) at δ 169.47 ppm.Table 2
Physical data for5a–5j.
Entry
Substitution R
Yield (%)
5a
4-OCH3 phenyl
85
5b
2-NO2 phenyl
95
5c
4-F phenyl
89
5d
3-Cl phenyl
77
5e
4-Br phenyl
90
5f
4-OH phenyl
73
5g
4-CH3 phenyl
84
5h
2-Cl phenyl
71
5i
4-NO2 phenyl
79
5j
3-Br phenyl
88Scheme 2
Reaction scheme for the synthesis of5a–5j.


## 3. Conclusion

In summary, an efficient protocol for the synthesis of new 1, 2, 4-aryl triazoles and 4-thiazolidinones has been described. Herein, we are reporting the solvent free protocol for the synthesis of N-substituted 1, 2, 4-aryl triazoles(4a–4j) from potassium salt(3). In literature, the synthesis of 4-thiazolidinones was carried out via 2 steps, but, to avoid multisteps and to make it more viable, we have developed a single-step reaction for the synthesis of 4-thiazolidinones(5a-5j) from hydrazide(2).


## 4. Experimental

Melting points were determined in open capillary tubes and are uncorrected. Formation of the compounds was checked by TLC on silica gel-G plates of 0.5 mm thickness. IR spectra were recorded on Shimadzu FT-IR-8400 instrument using DRS (diffusive reflectance system) method. Mass spectra were recorded on Shimadzu GC-MS system (model QP-2010) using direct inlet probe technique.1H NMR and 13C NMR were determined in CDCl3 and DMSO-d6 on a Bruker AC 400 MHz and 100 MHz spectrometer. Elemental analysis of all the synthesized compounds was carried out on Euro EA 3000 elemental analyzer and the results are in agreement with the structures assigned.


### 4.1. General Procedure for the Synthesis of Functionalized 1, 2, 4-Aryl Triazoles(4a–4j)

To a stirred solution of 6-fluorochroman-2-carboxylic acid (0.01 mol) in methanol at room temperature, concentrated H2SO4 (0.01 mol) was added and reaction mixture was allowed to stir at RT for 10 hours. After completion of the reaction, solvent was evaporated and the resulting mass was poured on to ice, neutralized with saturated sodium bicarbonate solution. Separated solid precipitate was filtered, washed with water, and dried to afford methyl 6-fluorochroman-2-carboxylate1.Compound1 (0.01 mol) in absolute ethanol was taken into the RBF and cooled at (−5)°C. To the previously cooled solution hydrazine hydrate (99%, 0.08 mol) was added and reaction mixture was allowed to stir at 0–(−5)°C for 10 hours. After the completion of reaction separated solid residues were filtered, washed with cold ethanol, and dried to afford 6-fluorochroman-2-carbohydrazide2, yield: 2.0 g (98%).To a mixture of compound2 (0.1 mol) and potassium hydroxide (0.15 mol) in methanol carbon disulphide (0.15 mol) was added dropwise. Reaction mass was allowed to stir at RT for 22–24 hours. After completion of reaction the obtained solid was filtered, washed with diethyl ether, and dried to afford compound3. There is no need to purify the salt for further reaction.An equimolar mixture of potassium 2-[(6-fluorochroman-2-yl) carbonyl] hydrazine carbodithioate3 (0.01 mol) and substituted aniline (0.01 mol) was taken in RBF and heated at 140–150°C for 12–15 hours until the evolution of H2S gas ceased. After completion of reaction solid residue was dissolved in DMF, treated with dilute HCl, and poured on crushed ice. The product was isolated and crystallized from ethanol to give compounds4a–4j as analytical pure product.


#### 4.1.1. 5-(6-Fluorochroman-2-yl)-4-(p-tolyl)-4H-1, 2, 4-triazole-3-thiol (4a)

Yield 89%, mp 170–172°C; IR (DRS): 3076(Ar, C–H str.), 2924(C–H str.), 2573(–SH str.), 1735(C=O str.), 1087(C–N str.), 1041(C–O–C str.) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 2.02–2.44(m, 5H, 2CH, 3CH), 2.65–2.96(m, 2H, 2CH), 4.83–4.90(dd, J
=
12.6 Hz, 6 Hz, 1H, CH), 6.60–6.64(m, 1H, ArH), 6.73–6.76(m, 2H, ArH), 7.05–7.49(m, 4H, ArH), 11.43(s, 1H, SH). 13C NMR (100 MHz, CDCl3): δ ppm 20.3(CH3), 26.27(CH2), 28.87(CH2), 85.3(CH), 108.52(CH), 112.98(CH), 116.81(CH), 119.54(CH), 129.2(C), 131.16(C), 133.09(CH), 136.12(C), 139.69(C), 155.8(C), 158.29(C), 173.99(C). MS:m/z = 341 [M]+; Anal. Calcd for C18H16FN3OS: C, 63.32; H, 4.72; N, 12.31. Found: C, 63.23; H, 4.41; N, 12.28%.


#### 4.1.2. 4-(3-Chlorophenyl)-5-(6-fluorochroman-2-yl)-4H-1, 2, 4-triazole-3-thiol (4b)

Yield 86%, mp 205–207°C; IR (DRS): 3066(Ar, C–H str.), 2914(C–H str.), 2850(C–H str.), 2533(–SH str.), 1558(Ar, C=C bend.), 1375(C–H ben), 800(C–Cl str.), 1087(C–N str.), 1041(C–O–C str.) cm−1; 1H NMR (400 MHz, DMSO-d6): δ ppm 2.27–2.30(m, 2H, 2CH), 2.82–2.95(m, 2H, 2CH), 4.92–4.95(dd, J
=
6.12 Hz, 12 Hz, 1H, CH), 6.50–6.54(m, 1H, ArH), 6.75–6.79(m, 2H, ArH), 7.41–7.43(m, 1H, ArH), 7.53–7.55(m, 3H, ArH), 14.0(s, 1H, SH). 13C NMR (100 MHz, DMSO-d6): δ ppm 25.27(CH2), 28.27(CH2), 85.3(CH), 112.98(CH), 116.81(CH), 120.08(CH), 122.3(CH), 125.68(CH), 129.2(C), 133.41(CH), 138.88(C), 139.69(C), 142.37(C), 155.8(C), 158.29(C), 173.99(C) MS:m/z = 361 [M]+; Anal. Calcd for C17H13ClFN3OS: C, 56.43; H, 3.62; N, 11.61. Found: C, 56.18; H, 3.49; N, 11.59%.


#### 4.1.3. 5-(6-Fluorochroman-2-yl)-4-(4-fluorophenyl)-4H-1, 2, 4-triazole-3-thiol (4c)

Yield 78%, mp 188–190°C; IR (DRS): 3030(Ar, C–H str.), 2558(–SH str.), 1581(–C=C–, str.), 1225(C–O–C str.) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 2.21–2.46(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.88–4.93(dd, J
=
12.6 Hz, 6 Hz, 1H, CH), 6.51–6.55(m, 1H, ArH), 6.77–6.81(m, 2H, ArH), 7.53–7.57(m, 3H, ArH), 13.05(s, 1H, SH). 13C NMR (100 MHz, CDCl3): 26.27(CH2), 28.87(CH2), 85.3(CH), 108.52(CH), 112.98(CH), 116.81(CH), 118.6(CH), 122.97(CH), 129.2(C), 133.7(C), 139.69(C), 155.8(C), 158.29(C), 160.51(C), 173.99(C). MS:m/z = 345 [M]+; Anal. Calcd for C17H13F2N3OS: C, 59.12; H, 3.79; N, 12.17. Found: C, 59.02; H, 3.53; N, 12.01%.


#### 4.1.4. 4-(2, 5-Dimethylphenyl)-5-(6-fluorochroman-2-yl)-4H-1, 2, 4-triazole-3-thiol (4d)

Yield 95%, mp 123–125°C; IR (DRS): 3074(Ar, C–H str.), 2984(C–H str.), 1645(–C=C–, str.), 1468(C–H bending) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 1.92(s, 6H, 3CH, 3CH), 2.21–2.46(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.85–4.92(dd, J
=
12.6 Hz, 6 Hz, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.29–7.43(m, 3H, ArH), 13.05(s, 1H, SH). 13C NMR (100 MHz, CDCl3): δ ppm 17.98(CH3), 26.87(CH2), 28.87(CH2), 30.2(CH3), 85.3(CH), 108.52(CH), 116.81(CH), 118.6(CH), 112.98(CH), 124.19(CH), 132.61(CH), 134.95(C), 138.13(C), 140.75(C), 146.2(C), 155.8(C), 158.29(C), 175.05(C). MS:m/z = 355 [M]+; Anal. Calcd for C19H18FN3OS: C, 64.21; H, 5.10; N, 11.82. Found: C, 64.16; H, 4.93; N, 11.78%.


#### 4.1.5. 4-(3, 4-Dimethylphenyl)-5-(6-fluorochroman-2-yl)-4H-1, 2, 4-triazole-3-thiol (4e)

Yield 84%, mp 163–165°C; IR (DRS): 3081(Ar, C–H str.), 2975(C–H str.), 2575(–SH str.), 1641(C–H bending), 1579(–C=C–, str.), 1142(C–F str.) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 2.34(s, 6H, 3CH, 3CH), 2.21–2.46(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.85–4.92(dd, J
=
12.6 Hz, 6 Hz, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.29–7.43(m, 3H, ArH), 13.05(s, 1H, SH). 13C NMR (100 MHz, CDCl3): δ ppm 19.0(CH3), 20.01(CH3), 26.27(CH2), 28.87(CH2), 85.3(CH), 112.98(CH), 116.81(CH), 117.91(CH), 124.04(CH), 129.2(C), 132.85(C), 133.52(C), 139.69(C), 141.78(C), 143.79(C), 155.8(C), 158.29(C), 173.998(C). MS:m/z = 355 [M]+; Anal. Calcd for C19H18FN3OS: C, 64.21; H, 5.10; N, 11.82. Found: C, 64.09; H, 5.03; N, 11.50%.


#### 4.1.6. 5-(6-Fluorochroman-2-yl)-4-(2-fluorophenyl)-4H-1, 2, 4-triazole-3-thiol (4f)

Yield 79%, mp 108–110°C; IR (DRS): 3080(Ar, C–H str.), 2983(C–H str.), 2561(–SH str.), 1629(C–H bending), 1572(C–H bending), 1525(–C=C–, str.) 1196(C–O–C str.) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 2.34(s, 6H, 3CH, 3CH), 2.21–2.46(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.90–4.97(dd, J
=
12.6 Hz, 6 Hz, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.24–7.75(m, 3H, ArH), 13.05(s, 1H, SH). 13C NMR (100 MHz, CDCl3): δ ppm 26.27(CH2), 28.87(CH2), 85.3(CH), 108.52(CH), 112.98(CH), 116.81(CH), 119.7(C), 119.58(CH), 129.2(C), 129.95(CH), 130.09(CH), 130.97(CH), 139.69(C), 155.8(C), 158.29(C), 162.56(C), 173.99(C). MS:m/z = 345 [M]+; Anal. Calcd for C17H13F2N3OS: C, 59.12; H, 3.79; N, 12.17. Found: C, 58.96; H, 3.67; N, 12.06%.


#### 4.1.7. 4-(2-Chlorophenyl)-5-(6-fluorochroman-2-yl)-4H-1, 2, 4-triazole-3-thiol (4g)

Yield 76%, mp 192–194°C; IR (DRS): 3077(Ar, C–H str.), 2978(C–H str.), 2563(–SH str.), 1563(–C=C–, str.), 1464(H–C–H bend), 1310(C–O str.), 870(C–Cl str.) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 2.34(s, 6H, 3CH, 3CH), 2.21–2.46(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.90–4.97(dd, J
=
12.6 Hz, 6 Hz, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.39–7.50(m, 3H, ArH), 13.05(s, 1H, SH). 13C NMR (100 MHz, CDCl3): δ ppm 26.27(CH2), 28.87(CH2), 85.3(CH), 108.52(CH), 112.98(CH), 116.81(CH), 127.83(CH), 126.39(C), 128.04(CH), 129.2(C), 131.85(CH), 132.57(CH), 140.8(C), 142.53(C), 155.8(C), 158.29(C), 175.1(C). MS:m/z = 361 [M]+; Anal. Calcd C17H13ClFN3OS: C, 56.43; H, 3.62; N, 11.61. Found: C, 55.97; H, 3.55; N, 11.59%.


#### 4.1.8. 4-(3-Chloro-4-fluorophenyl)-5-(6-fluorochroman-2-yl)-4H-1,2,4-triazole-3-thiol (4h)

Yield 87%, mp 139–141°C; IR (DRS): 3075(Ar, C–H str.), 2553(–SH str.), 1581(–C=C–, str.), 1423(H–C–H bend), 1281(C–O str.), 870(C–Cl str.) cm−1; 1H NMR (400 MHz, DMSO-d6): δ ppm 2.34(s, 6H, 3CH, 3CH), 2.21–2.46(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.90–4.97(dd, J
=
12.6 Hz, 6 Hz, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.18–7.79(m, 3H, ArH), 13.05(s, 1H, SH). 13C NMR (100 MHz, DMSO-d6): δ ppm 26.27(CH2), 28.87(CH2), 85.3(CH), 108.52(CH), 112.98(CH), 116.81(CH), 120.08(CH), 121.91(CH), 124.85(C), 125.71(CH), 129.2(C), 139.69(C), 141.09(C), 155.8(C), 156.41(C), 158.29(C), 173.99(C). MS:m/z = 379 [M]+; Anal. Calcd for C17H12ClF2N3OS: C, 53.76; H, 3.18; N, 11.06. Found: C, 53.69; H, 3.07; N, 10.90%.


#### 4.1.9. 5-(6-Fluorochroman-2-yl)-4-(2-methoxyphenyl)-4H-1, 2, 4-triazole-3-thiol (4i)

Yield 90%, mp 251–253°C; IR (DRS): 3075(Ar, C–H str.), 2553(–SH str.), 1581(–C=C–, str.), 1423(H–C–H bend), 1281(C–O str.), 870(C–Cl str.), 1080(C–F str.) cm−1; 1H NMR (400 MHz, DMSO-d6): δ ppm 2.34(s, 6H, 3CH, 3CH), 2.21–2.46(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 3.83(s, 3H, OCH3), 4.90–4.97(dd, J
=
12.6 Hz, 6 Hz, 1H, CH), 6.72–6.95(m, 3H, ArH), 6.99–7.51(m, 4H, ArH), 13.05(s, 1H, SH). 13C NMR (100 MHz, DMSO-d6): δ ppm 26.27(CH2), 28.87(CH2), 56.32(CH3), 85.3(CH), 108.52(CH), 112.98(CH), 115.51(CH), 116.81(CH), 120.83(CH), 123.69(CH), 129.2(C), 131.19(CH), 134.73(C), 139.24(C), 155.8(C), 157.76(C), 158.29(C), 173.54(C). MS:m/z = 357 [M]+; Anal. Calcd for C18H16FN3O2S: C, 60.49; H, 4.51; N, 11.76. Found: C, 60.39; H, 4.29; N, 11.37%.


#### 4.1.10. 4-(2, 5-Difluorophenyl)-5-(6-fluorochroman-2-yl)-4H-1,2,4-triazole-3-thiol (4j)

Yield 75%, mp 229–231°C; IR (DRS): 3061(Ar, C–H str.), 2951 (C–H str.), 2535(–SH str.), 1589(–C=C–, str.), 1462(H–C–H bend), 1520(C–O str.), 1075(C–F str.) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 2.34(s, 6H, 3CH, 3CH), 2.21–2.46(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 3.83(s, 3H, OCH3), 4.90–4.97(dd, J
=
12.6 Hz, 6 Hz, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.13–7.22(m, 3H, ArH), 13.05(s, 1H, SH). 13C NMR (100 MHz, CDCl3): 26.27(CH2), 28.87(CH2), 85.3(CH), 108.29(CH), 108.69(CH) 112.98(CH), 116.81(CH), 117.32(CH), 118.79(C), 127.11(CH), 129.2(C), 139.69 (C), 155.8(C), 158.29(C), 159.93(C), 173.54(C). MS:m/z = 363 [M]+; Anal. Calcd for C17H12F3N3O2S: C, 56.19; H, 3.33; N, 11.56. Found: C, 56.06; H, 3.14; N, 11.32%.


### 4.2. General Procedure for the Synthesis of Functionalized 4-Thiazolidinones5a–5j

An equimolar mixture of 6-fluorochroman-2-carbohydrazide2 (0.01 mol) and different aryl aldehydes (0.01 mol) was taken in RBF and to this, thioglycolic acid (mercaptoacetic acid) (0.29 mol) in toluene was added. Then reaction mixture was allowed to reflux in a Dean-Stark assembly with continuous stirring. After completion of the reaction (48 hrs monitoring by TLC), the content was cooled to room temperature and then neutralized with saturated sodium bicarbonate solution. The organic extracts were washed with water and dried over Na2SO4. The solvent was evaporatedin vacuo and the resulting crude product was purified by column chromatography to give the analytical pure compounds5a–5j. Column chromatography was carried out in hexane: ethyl acetate solvent system. Pure compound was eluted in 23% ethyl acetate in hexane.


#### 4.2.1. 6-Fluoro-N-(2-(4-methoxyphenyl)-4-oxothiazolidine-3-yl) chroman-2-carboxamide (5a)

Yield 85%, mp 98–100°C; IR (DRS): 3383(Amide–NH str.), 3081(Ar, C–H str.), 2958(C–H str.), 1714(C=O str.), 1688(amide C=O str.), 1542(–NH bend), 1365(C–F str.), 1278(C–O–C str.) cm−1; 1H NMR (400 MHz, DMSO-d6): δ ppm 2.15–2.40(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 3.83(s, 3H, OCH3), 4.69–4.72(d, J
=
16.0 Hz, 1H, CH), 3.91–3.95(d, J
=
15.6 Hz, 1H, CH), 4.69–4.72(dd, J
=
3.6 Hz, 3.2 Hz, 1H, CH), 5.92(s, 1H, CH), 6.72–6.95(m, 3H, ArH), 6.87–7.84(m, 4H, ArH), 8.0(s, 1H, NH), 13C NMR (100 MHz, DMSO-d6): δ ppm 25.25(CH2), 26.19(CH2), 34.2(CH2), 55.33(CH3), 70.50(CH), 85.58(CH), 108.7(CH), 112.44(CH), 114.1(CH), 116.43(CH), 126.91(CH), 129.9(C), 133.68(C), 154.35(C), 157.18 (C), 155.8(C), 158.08(C), 165.35(C), 169.36(C). MS:m/z = 402 [M]+; Anal. Calcd for C20H19FN2O4S: C, 59.69; H, 4.76; N, 6.96. Found: C, 59.23; H, 4.61; N, 6.88%.


#### 4.2.2. 6-Fluoro-N-(2-(2-nitrophenyl)-4-oxothiazolidine-3-yl) chroman-2-carboxamide (5b)

Yield 95%, mp 190–192°C; IR (DRS): 3392(Amide–NH str.), 3205(Ar, C–H str.), 1712(C=O str.), 1678(amide C=O str.), 1523(–NH bend), 1590(N=O str.), 1259(C–O–C str.), 1190(C–F str.) cm−1; 1H NMR (400 MHz, DMSO-d6): δ ppm 1.81–2.05(m, 2H, 2CH), 2.61–2.74(m, 2H, 2CH), 3.68–3.72(d, J
=
16.0 Hz, 1H, CH), 3.91–3.95(d, J
=
15.6 Hz, 1H, CH), 4.66–4.69(dd, J
=
3.6 Hz, 3.2 Hz, 1H, CH), 6.12(s, 1H, CH), 6.72–6.79(m, 1H, ArH), 6.84–6.91(m, 2H, ArH), 7.60–7.63(t, 1H, ArH), 7.78–7.87(m, 2H, ArH), 8.04–8.06(d, J
=
8.0 Hz, 1H, ArH), 10.43–10.46(d, J
=
11.6 Hz, 1H, NH). 13C NMR (100 MHz, DMSO-d6): δ ppm 25.25(CH2), 26.19(CH2), 34.2(CH2), 68.3(CH), 85.58(CH), 108.7(CH), 114.1(CH), 116.43(CH), 123.91(CH), 125.5(C), 129.87(CH), 129.9(C), 127.85(CH), 132.06(C), 149.87(C), 154.35(C), 157.18 (C), 169.36(C). MS:m/z = 417 [M]+; Anal. Calcd for C19H16FN3O5S: C, 54.67; H, 3.86; N, 10.07. Found: C, 54.58; H, 3.49; N, 9.99%.


#### 4.2.3. 6-Fluoro-N-(2-(4-fluorophenyl)-4-oxothiazolidine-3-yl) chroman-2-carboxamide (5c)

Yield 89%, mp 106–110°C; IR (DRS): 3487(Amide–NH str.), 3041(Ar, C–H str.), 1710(C=O str.), 1676(amide C=O str.), 1537(–NH bend), 1201(C–O–C str.), 1190(C–F str.) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 1.82–2.02(m, 2H, 2CH), 2.56–2.70(m, 2H, 2CH), 3.59–3.78(m, 2H, 2CH), 4.45–4.58(dd, J
=
10.52 Hz, 11.52 Hz, 1H, CH), 5.79–5.83(d, J
=
17.32 Hz, 1H, CH), 6.54–6.72(m, 3H, ArH), 6.86–6.90(t, 1H, ArH), 6.99–7.03(t, 1H, ArH), 7.20–7.22(t, 1H, ArH), 7.33–7.36(t, 1H, ArH), 8.05–8.13(d, J
=
29.44 Hz, 1H, NH). 13C NMR (100 MHz, CDCl3): δ ppm 25.25(CH2), 26.19(CH2), 34.2(CH2), 70.52(CH), 85.58(CH), 108.7(CH), 113.27(CH), 114.1(CH), 116.43(CH), 127.64(CH), 129.9(C), 136.68(C), 154.35(C), 157.18 (C), 160.07(C), 165.35(C), 169.36(C). MS:m/z = 390 [M]+; Anal. Calcd for C19H16F2N2O3S: C, 58.45; H, 4.13; N, 7.18. Found: C, 58.02; H, 4.03; N, 7.10%.


#### 4.2.4.N
-(2-(3-Chlorophenyl)-4-oxothiazolidine-3-yl)-6-fluorochroman-2-carboxamide (5d)

Yield 77%, mp 151–153°C; IR (DRS): 3401(Amide–NH str.), 3200(Ar, C–H str.), 1717(C=O str.), 1645(amide C=O str.), 1550(–NH bend), 1245(C–F str.), 1201(C–O–C str.), 820(C–Cl str.) cm−1; 1H NMR (400 MHz, DMSO): δ ppm 2.15–2.40(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.66–4.69(d, J
=
16.0 Hz, 1H, CH), 3.91–3.95(d, J
=
15.6 Hz, 1H, CH), 4.69–4.72(dd, J
=
3.6 Hz, 3.2 Hz, 1H, CH), 5.92(s, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.24–7.43(m, 4H, ArH), 8.0(s, 1H, NH). 13C NMR (100 MHz, CDCl3): δ ppm 25.25(CH2), 26.19(CH2), 34.2(CH2), 71.78(CH), 85.58(CH), 108.7(CH), 114.1(CH), 116.43(CH), 124.5(CH), 124.93(CH), 126.41(CH), 128(CH), 132.25(C), 140.45(C), 145.35(C), 157.18 (C), 165.35(C), 169.36(C). MS:m/z = 406 [M]+; Anal. Calcd for C19H16ClFN2O3S: C, 56.09; H, 3.96; N, 6.89. Found: C, 55.90; H, 3.83; N, 6.83%.


#### 4.2.5.N-(2-(4-Bromophenyl)-4-oxothiazolidine-3-yl)-6-fluorochroman-2-carboxamide (5e)

Yield 90%, mp 118–120°C; IR (DRS): 3452(Amide–NH str.), 3000(Ar, C–H str.), 1725(C=O str.), 1640(amide C=O str.), 1545(–NH bend), 1345(C–F str.), 1251(C–O–C str.), 520(C–Br str.) cm−1; 1H NMR (400 MHz, DMSO-d6): δ ppm 2.15–2.40(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.63–4.66(d, J
=
16.0 Hz, 1H, CH), 3.91–3.95(d, J
=
15.6 Hz, 1H, CH), 4.63–4.66(dd, J
=
3.6 Hz, 3.2 Hz, 1H, CH), 5.92(s, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.12–7.85(m, 4H, ArH), 8.0(s, 1H, NH). 13C NMR (100 MHz, DMSO-d6): δ ppm 25.25(CH2), 26.19(CH2), 34.2(CH2), 70.50(CH), 85.58(CH), 108.7(CH), 114.1(CH), 116.43(CH), 120.41(C), 126.7(CH), 129.36(CH), 129.9(C), 138.93(C), 154.35(C), 157.18 (C), 165.35(C), 169.36(C). MS:m/z = 452 [M+1]+; Anal. Calcd for C19H16BrFN2O3S: C, 50.56; H, 3.57; N, 6.21. Found: C, 50.45; H, 3.28; N, 6.11%.


#### 4.2.6. 6-Fluoro-N-(2-(4-hydroxyphenyl)-4-oxothiazolidine-3-yl) chroman-2-carboxamide (5f)

Yield 73%, mp 132–134°C; IR (DRS): 3452(Amide–NH str.), (–OH, broad), 3011(Ar, C–H str.), 1728(C=O str.), 1645(amide C=O str.), 1545(–NH bend), 1352(C–F str.), 1278(C–O–C str.) cm−1; 1H NMR (400 MHz, DMSO-d6): δ ppm 2.15–2.40(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.63–4.66(d, J
=
16.0 Hz, 1H, CH), 3.91–3.95(d, J
=
15.6 Hz, 1H, CH), 4.63–4.66(dd, J
=
3.6 Hz, 3.2 Hz, 1H, CH), 5.35(s, 1H, OH), 5.92(s, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.14–7.86(m, 4H, ArH), 8.0(s, 1H, NH). 13C NMR (100 MHz, DMSO-d6): δ ppm 25.25(CH2), 26.19(CH2), 34.2(CH2), 55.33(CH3), 70.50(CH), 85.58(CH), 108.7(CH), 114.1(CH), 116.43(CH), 116.68(C), 125.81(CH), 129.9(C), 132.68(C), 154.35(C), 157.46 (C), 157.18(C), 165.35(C), 169.36(C). MS:m/z = 388 [M]+; Anal. Calcd for C19H17FN2O4S: C, 58.75; H, 4.41; N, 7.21. Found: C, 58.56; H, 4.34; N, 7.06%.


#### 4.2.7. 6-Fluoro-N-(4-oxo-2-(p-tolyl) thiazolidin-3-yl) chroman-2-carboxamide (5g)

Yield 84%, mp 89–91°C; IR (DRS): 3328(Amide–NH str.), 2998(Ar, C–H str.), 2900(C–H str.), 1741(C=O str.), 1652(amide C=O str.), 1548(–NH bend), 1371(C–F str.), 1300(C–O–C str.) cm−1; 1H NMR (400 MHz, DMSO-d6): δ ppm 2.15–2.32(m, 2H, 2CH), 2.34(s, 3H, 3CH), 2.75–2.85(m, 2H, 2CH), 4.63–4.66(d, J
=
16.0 Hz, 1H, CH), 3.91–3.95(d, J
=
15.6 Hz, 1H, CH), 4.63–4.66(dd, J
=
3.6 Hz, 3.2 Hz, 1H, CH), 5.92(s, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.11(m, 4H, ArH), 8.0(s, 1H, NH). 13C NMR (100 MHz, DMSO-d6): δ ppm 21.03(CH3), 25.25(CH2), 26.19(CH2), 34.2(CH2), 70.50(CH), 85.58(CH), 108.7(CH), 114.1(CH), 116.43(CH), 126.73(CH), 127.98(CH), 129.9(C), 136.48(C), 136.52(C), 154.35(C), 157.18(C), 165.35(C), 169.36(C). MS:m/z = 386 [M]+; Anal. Calcd C20H19FN2O3S: C, 62.16; H, 4.96; N, 7.25. Found: C, 62.07; H, 4.55; N, 7.09%.


#### 4.2.8.N-(2-(2-Chlorophenyl)-4-oxothiazolidine-3-yl)-6-fluorochroman-2-carboxamide (5h)

Yield 71%, mp 158–160°C; IR (DRS): 3412(Amide–NH str.), 3212(Ar, C–H str.), 1725(C=O str.), 1685(amide C=O str.), 1558(–NH bend), 1251(C–F str.), 1228(C–O–C str.), 800(C–Cl str.), 770(o-di substituted) cm−1; 1H NMR (400 MHz, DMSO): δ ppm 2.15–2.32(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.63–4.66(d, J
=
16.0 Hz, 1H, CH), 3.91–3.95(d, J
=
15.6 Hz, 1H, CH), 4.63–4.66(dd, J
=
3.6 Hz, 3.2 Hz, 1H, CH), 5.92(s, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.17–7.65(m, 4H, ArH), 8.0(s, 1H, NH). 13C NMR (100 MHz, CDCl3): δ ppm 25.25(CH2), 26.19(CH2), 34.2(CH2), 67.50(CH), 85.58(CH), 108.7(CH), 114.1(CH), 116.43(CH), 125.18(CH), 125.89(CH), 127.02(CH), 127.26(CH), 129.9(C), 131.68(C), 133.39(C), 154.35(C), 157.18 (C), 165.35(C), 169.36(C). MS:m/z = 406 [M]+; Anal. Calcd for C19H16ClFN2O3S: C, 56.09; H, 3.96; N, 6.89. Found: C, 55.93; H, 3.77; N, 6.84%.


#### 4.2.9. 6-Fluoro-N-(2-(4-nitrophenyl)-4-oxothiazolidine-3-yl) chroman-2-carboxamide (5i)

Yield 79%, mp 207–209°C; IR (DRS): 3398(Amide–NH str.), 3212(Ar, C–H str.), 1728(C=O str.), 1688(amide C=O str.), 1543(–NH bend), 1595(N=O str.), 1272(C–O–C str.), 1290(C–F str.) 790(p-di substituted) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 2.15–2.32(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.63–4.66(d, J
=
16.0 Hz, 1H, CH), 3.91–3.95(d, J
=
15.6 Hz, 1H, CH), 4.63–4.66(dd, J
=
3.6 Hz, 3.2 Hz, 1H, CH), 5.92(s, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.49–8.14(m, 4H, ArH), 8.0(s, 1H, NH). 13C NMR (100 MHz, CDCl3): δ ppm 25.25(CH2), 26.19(CH2), 34.2(CH2), 70.52(CH), 85.58(CH), 108.7(CH), 114.1(CH), 116.43(CH), 122.91(CH), 126.32(CH), 129.9(C), 144.08(C), 145.35(C), 154.35 (C), 157.18(C), 165.35(C), 169.36(C). MS:m/z = 417 [M]+; Anal. Calcd for C17H14FN3O2: C, 54.67; H, 3.86; N, 10.07. Found: C, 54.39; H, 3.79; N, 9.89%.


#### 4.2.10.N-(2-(3-Bromophenyl)-4-oxothiazolidine-3-yl)-6-fluorochroman-2-carboxamide (5j)

Yield 88%, mp 166–168°C; IR (DRS): 3482(Amide–NH str.), 3110(Ar, C–H str.), 1745(C=O str.), 1590(amide C=O str.), 1485(–NH bend), 1354(C–F str.), 1281(C–O–C str.), 680(m-di substituted), 520(C–Br str.) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 2.15–2.32(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.63–4.66(d, J
=
16.0 Hz, 1H, CH), 3.91–3.95(d, J
=
15.6 Hz, 1H, CH), 4.63–4.66(dd, J
=
3.6 Hz, 3.2 Hz, 1H, CH), 5.92(s, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.22–7.41(m, 4H, ArH), 8.0(s, 1H, NH). 13C NMR (100 MHz, CDCl3): δ ppm 25.25(CH2), 26.19(CH2), 34.2(CH2), 70.32(CH), 85.58(CH), 108.7(CH), 114.1(CH), 116.43(CH), 120.91(C), 127.55(CH), 127.95(CH), 128.17(CH), 128.74(CH), 129.9(C), 140.65(C), 154.35(C), 157.18 (C), 165.35(C), 169.36(C).MS:m/z = 452 [M+1] +; Anal. Calcd for C19H16FN3O5S: C, 50.56; H, 3.57; N, 6.21. Found: C, 50.17; H, 3.14; N, 6.12%.


## 4.1. General Procedure for the Synthesis of Functionalized 1, 2, 4-Aryl Triazoles(4a–4j)

To a stirred solution of 6-fluorochroman-2-carboxylic acid (0.01 mol) in methanol at room temperature, concentrated H2SO4 (0.01 mol) was added and reaction mixture was allowed to stir at RT for 10 hours. After completion of the reaction, solvent was evaporated and the resulting mass was poured on to ice, neutralized with saturated sodium bicarbonate solution. Separated solid precipitate was filtered, washed with water, and dried to afford methyl 6-fluorochroman-2-carboxylate1.Compound1 (0.01 mol) in absolute ethanol was taken into the RBF and cooled at (−5)°C. To the previously cooled solution hydrazine hydrate (99%, 0.08 mol) was added and reaction mixture was allowed to stir at 0–(−5)°C for 10 hours. After the completion of reaction separated solid residues were filtered, washed with cold ethanol, and dried to afford 6-fluorochroman-2-carbohydrazide2, yield: 2.0 g (98%).To a mixture of compound2 (0.1 mol) and potassium hydroxide (0.15 mol) in methanol carbon disulphide (0.15 mol) was added dropwise. Reaction mass was allowed to stir at RT for 22–24 hours. After completion of reaction the obtained solid was filtered, washed with diethyl ether, and dried to afford compound3. There is no need to purify the salt for further reaction.An equimolar mixture of potassium 2-[(6-fluorochroman-2-yl) carbonyl] hydrazine carbodithioate3 (0.01 mol) and substituted aniline (0.01 mol) was taken in RBF and heated at 140–150°C for 12–15 hours until the evolution of H2S gas ceased. After completion of reaction solid residue was dissolved in DMF, treated with dilute HCl, and poured on crushed ice. The product was isolated and crystallized from ethanol to give compounds4a–4j as analytical pure product.


### 4.1.1. 5-(6-Fluorochroman-2-yl)-4-(p-tolyl)-4H-1, 2, 4-triazole-3-thiol (4a)

Yield 89%, mp 170–172°C; IR (DRS): 3076(Ar, C–H str.), 2924(C–H str.), 2573(–SH str.), 1735(C=O str.), 1087(C–N str.), 1041(C–O–C str.) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 2.02–2.44(m, 5H, 2CH, 3CH), 2.65–2.96(m, 2H, 2CH), 4.83–4.90(dd, J
=
12.6 Hz, 6 Hz, 1H, CH), 6.60–6.64(m, 1H, ArH), 6.73–6.76(m, 2H, ArH), 7.05–7.49(m, 4H, ArH), 11.43(s, 1H, SH). 13C NMR (100 MHz, CDCl3): δ ppm 20.3(CH3), 26.27(CH2), 28.87(CH2), 85.3(CH), 108.52(CH), 112.98(CH), 116.81(CH), 119.54(CH), 129.2(C), 131.16(C), 133.09(CH), 136.12(C), 139.69(C), 155.8(C), 158.29(C), 173.99(C). MS:m/z = 341 [M]+; Anal. Calcd for C18H16FN3OS: C, 63.32; H, 4.72; N, 12.31. Found: C, 63.23; H, 4.41; N, 12.28%.


### 4.1.2. 4-(3-Chlorophenyl)-5-(6-fluorochroman-2-yl)-4H-1, 2, 4-triazole-3-thiol (4b)

Yield 86%, mp 205–207°C; IR (DRS): 3066(Ar, C–H str.), 2914(C–H str.), 2850(C–H str.), 2533(–SH str.), 1558(Ar, C=C bend.), 1375(C–H ben), 800(C–Cl str.), 1087(C–N str.), 1041(C–O–C str.) cm−1; 1H NMR (400 MHz, DMSO-d6): δ ppm 2.27–2.30(m, 2H, 2CH), 2.82–2.95(m, 2H, 2CH), 4.92–4.95(dd, J
=
6.12 Hz, 12 Hz, 1H, CH), 6.50–6.54(m, 1H, ArH), 6.75–6.79(m, 2H, ArH), 7.41–7.43(m, 1H, ArH), 7.53–7.55(m, 3H, ArH), 14.0(s, 1H, SH). 13C NMR (100 MHz, DMSO-d6): δ ppm 25.27(CH2), 28.27(CH2), 85.3(CH), 112.98(CH), 116.81(CH), 120.08(CH), 122.3(CH), 125.68(CH), 129.2(C), 133.41(CH), 138.88(C), 139.69(C), 142.37(C), 155.8(C), 158.29(C), 173.99(C) MS:m/z = 361 [M]+; Anal. Calcd for C17H13ClFN3OS: C, 56.43; H, 3.62; N, 11.61. Found: C, 56.18; H, 3.49; N, 11.59%.


### 4.1.3. 5-(6-Fluorochroman-2-yl)-4-(4-fluorophenyl)-4H-1, 2, 4-triazole-3-thiol (4c)

Yield 78%, mp 188–190°C; IR (DRS): 3030(Ar, C–H str.), 2558(–SH str.), 1581(–C=C–, str.), 1225(C–O–C str.) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 2.21–2.46(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.88–4.93(dd, J
=
12.6 Hz, 6 Hz, 1H, CH), 6.51–6.55(m, 1H, ArH), 6.77–6.81(m, 2H, ArH), 7.53–7.57(m, 3H, ArH), 13.05(s, 1H, SH). 13C NMR (100 MHz, CDCl3): 26.27(CH2), 28.87(CH2), 85.3(CH), 108.52(CH), 112.98(CH), 116.81(CH), 118.6(CH), 122.97(CH), 129.2(C), 133.7(C), 139.69(C), 155.8(C), 158.29(C), 160.51(C), 173.99(C). MS:m/z = 345 [M]+; Anal. Calcd for C17H13F2N3OS: C, 59.12; H, 3.79; N, 12.17. Found: C, 59.02; H, 3.53; N, 12.01%.


### 4.1.4. 4-(2, 5-Dimethylphenyl)-5-(6-fluorochroman-2-yl)-4H-1, 2, 4-triazole-3-thiol (4d)

Yield 95%, mp 123–125°C; IR (DRS): 3074(Ar, C–H str.), 2984(C–H str.), 1645(–C=C–, str.), 1468(C–H bending) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 1.92(s, 6H, 3CH, 3CH), 2.21–2.46(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.85–4.92(dd, J
=
12.6 Hz, 6 Hz, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.29–7.43(m, 3H, ArH), 13.05(s, 1H, SH). 13C NMR (100 MHz, CDCl3): δ ppm 17.98(CH3), 26.87(CH2), 28.87(CH2), 30.2(CH3), 85.3(CH), 108.52(CH), 116.81(CH), 118.6(CH), 112.98(CH), 124.19(CH), 132.61(CH), 134.95(C), 138.13(C), 140.75(C), 146.2(C), 155.8(C), 158.29(C), 175.05(C). MS:m/z = 355 [M]+; Anal. Calcd for C19H18FN3OS: C, 64.21; H, 5.10; N, 11.82. Found: C, 64.16; H, 4.93; N, 11.78%.


### 4.1.5. 4-(3, 4-Dimethylphenyl)-5-(6-fluorochroman-2-yl)-4H-1, 2, 4-triazole-3-thiol (4e)

Yield 84%, mp 163–165°C; IR (DRS): 3081(Ar, C–H str.), 2975(C–H str.), 2575(–SH str.), 1641(C–H bending), 1579(–C=C–, str.), 1142(C–F str.) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 2.34(s, 6H, 3CH, 3CH), 2.21–2.46(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.85–4.92(dd, J
=
12.6 Hz, 6 Hz, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.29–7.43(m, 3H, ArH), 13.05(s, 1H, SH). 13C NMR (100 MHz, CDCl3): δ ppm 19.0(CH3), 20.01(CH3), 26.27(CH2), 28.87(CH2), 85.3(CH), 112.98(CH), 116.81(CH), 117.91(CH), 124.04(CH), 129.2(C), 132.85(C), 133.52(C), 139.69(C), 141.78(C), 143.79(C), 155.8(C), 158.29(C), 173.998(C). MS:m/z = 355 [M]+; Anal. Calcd for C19H18FN3OS: C, 64.21; H, 5.10; N, 11.82. Found: C, 64.09; H, 5.03; N, 11.50%.


### 4.1.6. 5-(6-Fluorochroman-2-yl)-4-(2-fluorophenyl)-4H-1, 2, 4-triazole-3-thiol (4f)

Yield 79%, mp 108–110°C; IR (DRS): 3080(Ar, C–H str.), 2983(C–H str.), 2561(–SH str.), 1629(C–H bending), 1572(C–H bending), 1525(–C=C–, str.) 1196(C–O–C str.) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 2.34(s, 6H, 3CH, 3CH), 2.21–2.46(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.90–4.97(dd, J
=
12.6 Hz, 6 Hz, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.24–7.75(m, 3H, ArH), 13.05(s, 1H, SH). 13C NMR (100 MHz, CDCl3): δ ppm 26.27(CH2), 28.87(CH2), 85.3(CH), 108.52(CH), 112.98(CH), 116.81(CH), 119.7(C), 119.58(CH), 129.2(C), 129.95(CH), 130.09(CH), 130.97(CH), 139.69(C), 155.8(C), 158.29(C), 162.56(C), 173.99(C). MS:m/z = 345 [M]+; Anal. Calcd for C17H13F2N3OS: C, 59.12; H, 3.79; N, 12.17. Found: C, 58.96; H, 3.67; N, 12.06%.


### 4.1.7. 4-(2-Chlorophenyl)-5-(6-fluorochroman-2-yl)-4H-1, 2, 4-triazole-3-thiol (4g)

Yield 76%, mp 192–194°C; IR (DRS): 3077(Ar, C–H str.), 2978(C–H str.), 2563(–SH str.), 1563(–C=C–, str.), 1464(H–C–H bend), 1310(C–O str.), 870(C–Cl str.) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 2.34(s, 6H, 3CH, 3CH), 2.21–2.46(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.90–4.97(dd, J
=
12.6 Hz, 6 Hz, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.39–7.50(m, 3H, ArH), 13.05(s, 1H, SH). 13C NMR (100 MHz, CDCl3): δ ppm 26.27(CH2), 28.87(CH2), 85.3(CH), 108.52(CH), 112.98(CH), 116.81(CH), 127.83(CH), 126.39(C), 128.04(CH), 129.2(C), 131.85(CH), 132.57(CH), 140.8(C), 142.53(C), 155.8(C), 158.29(C), 175.1(C). MS:m/z = 361 [M]+; Anal. Calcd C17H13ClFN3OS: C, 56.43; H, 3.62; N, 11.61. Found: C, 55.97; H, 3.55; N, 11.59%.


### 4.1.8. 4-(3-Chloro-4-fluorophenyl)-5-(6-fluorochroman-2-yl)-4H-1,2,4-triazole-3-thiol (4h)

Yield 87%, mp 139–141°C; IR (DRS): 3075(Ar, C–H str.), 2553(–SH str.), 1581(–C=C–, str.), 1423(H–C–H bend), 1281(C–O str.), 870(C–Cl str.) cm−1; 1H NMR (400 MHz, DMSO-d6): δ ppm 2.34(s, 6H, 3CH, 3CH), 2.21–2.46(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.90–4.97(dd, J
=
12.6 Hz, 6 Hz, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.18–7.79(m, 3H, ArH), 13.05(s, 1H, SH). 13C NMR (100 MHz, DMSO-d6): δ ppm 26.27(CH2), 28.87(CH2), 85.3(CH), 108.52(CH), 112.98(CH), 116.81(CH), 120.08(CH), 121.91(CH), 124.85(C), 125.71(CH), 129.2(C), 139.69(C), 141.09(C), 155.8(C), 156.41(C), 158.29(C), 173.99(C). MS:m/z = 379 [M]+; Anal. Calcd for C17H12ClF2N3OS: C, 53.76; H, 3.18; N, 11.06. Found: C, 53.69; H, 3.07; N, 10.90%.


### 4.1.9. 5-(6-Fluorochroman-2-yl)-4-(2-methoxyphenyl)-4H-1, 2, 4-triazole-3-thiol (4i)

Yield 90%, mp 251–253°C; IR (DRS): 3075(Ar, C–H str.), 2553(–SH str.), 1581(–C=C–, str.), 1423(H–C–H bend), 1281(C–O str.), 870(C–Cl str.), 1080(C–F str.) cm−1; 1H NMR (400 MHz, DMSO-d6): δ ppm 2.34(s, 6H, 3CH, 3CH), 2.21–2.46(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 3.83(s, 3H, OCH3), 4.90–4.97(dd, J
=
12.6 Hz, 6 Hz, 1H, CH), 6.72–6.95(m, 3H, ArH), 6.99–7.51(m, 4H, ArH), 13.05(s, 1H, SH). 13C NMR (100 MHz, DMSO-d6): δ ppm 26.27(CH2), 28.87(CH2), 56.32(CH3), 85.3(CH), 108.52(CH), 112.98(CH), 115.51(CH), 116.81(CH), 120.83(CH), 123.69(CH), 129.2(C), 131.19(CH), 134.73(C), 139.24(C), 155.8(C), 157.76(C), 158.29(C), 173.54(C). MS:m/z = 357 [M]+; Anal. Calcd for C18H16FN3O2S: C, 60.49; H, 4.51; N, 11.76. Found: C, 60.39; H, 4.29; N, 11.37%.


### 4.1.10. 4-(2, 5-Difluorophenyl)-5-(6-fluorochroman-2-yl)-4H-1,2,4-triazole-3-thiol (4j)

Yield 75%, mp 229–231°C; IR (DRS): 3061(Ar, C–H str.), 2951 (C–H str.), 2535(–SH str.), 1589(–C=C–, str.), 1462(H–C–H bend), 1520(C–O str.), 1075(C–F str.) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 2.34(s, 6H, 3CH, 3CH), 2.21–2.46(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 3.83(s, 3H, OCH3), 4.90–4.97(dd, J
=
12.6 Hz, 6 Hz, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.13–7.22(m, 3H, ArH), 13.05(s, 1H, SH). 13C NMR (100 MHz, CDCl3): 26.27(CH2), 28.87(CH2), 85.3(CH), 108.29(CH), 108.69(CH) 112.98(CH), 116.81(CH), 117.32(CH), 118.79(C), 127.11(CH), 129.2(C), 139.69 (C), 155.8(C), 158.29(C), 159.93(C), 173.54(C). MS:m/z = 363 [M]+; Anal. Calcd for C17H12F3N3O2S: C, 56.19; H, 3.33; N, 11.56. Found: C, 56.06; H, 3.14; N, 11.32%.


## 4.1.1. 5-(6-Fluorochroman-2-yl)-4-(p-tolyl)-4H-1, 2, 4-triazole-3-thiol (4a)

Yield 89%, mp 170–172°C; IR (DRS): 3076(Ar, C–H str.), 2924(C–H str.), 2573(–SH str.), 1735(C=O str.), 1087(C–N str.), 1041(C–O–C str.) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 2.02–2.44(m, 5H, 2CH, 3CH), 2.65–2.96(m, 2H, 2CH), 4.83–4.90(dd, J
=
12.6 Hz, 6 Hz, 1H, CH), 6.60–6.64(m, 1H, ArH), 6.73–6.76(m, 2H, ArH), 7.05–7.49(m, 4H, ArH), 11.43(s, 1H, SH). 13C NMR (100 MHz, CDCl3): δ ppm 20.3(CH3), 26.27(CH2), 28.87(CH2), 85.3(CH), 108.52(CH), 112.98(CH), 116.81(CH), 119.54(CH), 129.2(C), 131.16(C), 133.09(CH), 136.12(C), 139.69(C), 155.8(C), 158.29(C), 173.99(C). MS:m/z = 341 [M]+; Anal. Calcd for C18H16FN3OS: C, 63.32; H, 4.72; N, 12.31. Found: C, 63.23; H, 4.41; N, 12.28%.


## 4.1.2. 4-(3-Chlorophenyl)-5-(6-fluorochroman-2-yl)-4H-1, 2, 4-triazole-3-thiol (4b)

Yield 86%, mp 205–207°C; IR (DRS): 3066(Ar, C–H str.), 2914(C–H str.), 2850(C–H str.), 2533(–SH str.), 1558(Ar, C=C bend.), 1375(C–H ben), 800(C–Cl str.), 1087(C–N str.), 1041(C–O–C str.) cm−1; 1H NMR (400 MHz, DMSO-d6): δ ppm 2.27–2.30(m, 2H, 2CH), 2.82–2.95(m, 2H, 2CH), 4.92–4.95(dd, J
=
6.12 Hz, 12 Hz, 1H, CH), 6.50–6.54(m, 1H, ArH), 6.75–6.79(m, 2H, ArH), 7.41–7.43(m, 1H, ArH), 7.53–7.55(m, 3H, ArH), 14.0(s, 1H, SH). 13C NMR (100 MHz, DMSO-d6): δ ppm 25.27(CH2), 28.27(CH2), 85.3(CH), 112.98(CH), 116.81(CH), 120.08(CH), 122.3(CH), 125.68(CH), 129.2(C), 133.41(CH), 138.88(C), 139.69(C), 142.37(C), 155.8(C), 158.29(C), 173.99(C) MS:m/z = 361 [M]+; Anal. Calcd for C17H13ClFN3OS: C, 56.43; H, 3.62; N, 11.61. Found: C, 56.18; H, 3.49; N, 11.59%.


## 4.1.3. 5-(6-Fluorochroman-2-yl)-4-(4-fluorophenyl)-4H-1, 2, 4-triazole-3-thiol (4c)

Yield 78%, mp 188–190°C; IR (DRS): 3030(Ar, C–H str.), 2558(–SH str.), 1581(–C=C–, str.), 1225(C–O–C str.) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 2.21–2.46(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.88–4.93(dd, J
=
12.6 Hz, 6 Hz, 1H, CH), 6.51–6.55(m, 1H, ArH), 6.77–6.81(m, 2H, ArH), 7.53–7.57(m, 3H, ArH), 13.05(s, 1H, SH). 13C NMR (100 MHz, CDCl3): 26.27(CH2), 28.87(CH2), 85.3(CH), 108.52(CH), 112.98(CH), 116.81(CH), 118.6(CH), 122.97(CH), 129.2(C), 133.7(C), 139.69(C), 155.8(C), 158.29(C), 160.51(C), 173.99(C). MS:m/z = 345 [M]+; Anal. Calcd for C17H13F2N3OS: C, 59.12; H, 3.79; N, 12.17. Found: C, 59.02; H, 3.53; N, 12.01%.


## 4.1.4. 4-(2, 5-Dimethylphenyl)-5-(6-fluorochroman-2-yl)-4H-1, 2, 4-triazole-3-thiol (4d)

Yield 95%, mp 123–125°C; IR (DRS): 3074(Ar, C–H str.), 2984(C–H str.), 1645(–C=C–, str.), 1468(C–H bending) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 1.92(s, 6H, 3CH, 3CH), 2.21–2.46(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.85–4.92(dd, J
=
12.6 Hz, 6 Hz, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.29–7.43(m, 3H, ArH), 13.05(s, 1H, SH). 13C NMR (100 MHz, CDCl3): δ ppm 17.98(CH3), 26.87(CH2), 28.87(CH2), 30.2(CH3), 85.3(CH), 108.52(CH), 116.81(CH), 118.6(CH), 112.98(CH), 124.19(CH), 132.61(CH), 134.95(C), 138.13(C), 140.75(C), 146.2(C), 155.8(C), 158.29(C), 175.05(C). MS:m/z = 355 [M]+; Anal. Calcd for C19H18FN3OS: C, 64.21; H, 5.10; N, 11.82. Found: C, 64.16; H, 4.93; N, 11.78%.


## 4.1.5. 4-(3, 4-Dimethylphenyl)-5-(6-fluorochroman-2-yl)-4H-1, 2, 4-triazole-3-thiol (4e)

Yield 84%, mp 163–165°C; IR (DRS): 3081(Ar, C–H str.), 2975(C–H str.), 2575(–SH str.), 1641(C–H bending), 1579(–C=C–, str.), 1142(C–F str.) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 2.34(s, 6H, 3CH, 3CH), 2.21–2.46(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.85–4.92(dd, J
=
12.6 Hz, 6 Hz, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.29–7.43(m, 3H, ArH), 13.05(s, 1H, SH). 13C NMR (100 MHz, CDCl3): δ ppm 19.0(CH3), 20.01(CH3), 26.27(CH2), 28.87(CH2), 85.3(CH), 112.98(CH), 116.81(CH), 117.91(CH), 124.04(CH), 129.2(C), 132.85(C), 133.52(C), 139.69(C), 141.78(C), 143.79(C), 155.8(C), 158.29(C), 173.998(C). MS:m/z = 355 [M]+; Anal. Calcd for C19H18FN3OS: C, 64.21; H, 5.10; N, 11.82. Found: C, 64.09; H, 5.03; N, 11.50%.


## 4.1.6. 5-(6-Fluorochroman-2-yl)-4-(2-fluorophenyl)-4H-1, 2, 4-triazole-3-thiol (4f)

Yield 79%, mp 108–110°C; IR (DRS): 3080(Ar, C–H str.), 2983(C–H str.), 2561(–SH str.), 1629(C–H bending), 1572(C–H bending), 1525(–C=C–, str.) 1196(C–O–C str.) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 2.34(s, 6H, 3CH, 3CH), 2.21–2.46(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.90–4.97(dd, J
=
12.6 Hz, 6 Hz, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.24–7.75(m, 3H, ArH), 13.05(s, 1H, SH). 13C NMR (100 MHz, CDCl3): δ ppm 26.27(CH2), 28.87(CH2), 85.3(CH), 108.52(CH), 112.98(CH), 116.81(CH), 119.7(C), 119.58(CH), 129.2(C), 129.95(CH), 130.09(CH), 130.97(CH), 139.69(C), 155.8(C), 158.29(C), 162.56(C), 173.99(C). MS:m/z = 345 [M]+; Anal. Calcd for C17H13F2N3OS: C, 59.12; H, 3.79; N, 12.17. Found: C, 58.96; H, 3.67; N, 12.06%.


## 4.1.7. 4-(2-Chlorophenyl)-5-(6-fluorochroman-2-yl)-4H-1, 2, 4-triazole-3-thiol (4g)

Yield 76%, mp 192–194°C; IR (DRS): 3077(Ar, C–H str.), 2978(C–H str.), 2563(–SH str.), 1563(–C=C–, str.), 1464(H–C–H bend), 1310(C–O str.), 870(C–Cl str.) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 2.34(s, 6H, 3CH, 3CH), 2.21–2.46(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.90–4.97(dd, J
=
12.6 Hz, 6 Hz, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.39–7.50(m, 3H, ArH), 13.05(s, 1H, SH). 13C NMR (100 MHz, CDCl3): δ ppm 26.27(CH2), 28.87(CH2), 85.3(CH), 108.52(CH), 112.98(CH), 116.81(CH), 127.83(CH), 126.39(C), 128.04(CH), 129.2(C), 131.85(CH), 132.57(CH), 140.8(C), 142.53(C), 155.8(C), 158.29(C), 175.1(C). MS:m/z = 361 [M]+; Anal. Calcd C17H13ClFN3OS: C, 56.43; H, 3.62; N, 11.61. Found: C, 55.97; H, 3.55; N, 11.59%.


## 4.1.8. 4-(3-Chloro-4-fluorophenyl)-5-(6-fluorochroman-2-yl)-4H-1,2,4-triazole-3-thiol (4h)

Yield 87%, mp 139–141°C; IR (DRS): 3075(Ar, C–H str.), 2553(–SH str.), 1581(–C=C–, str.), 1423(H–C–H bend), 1281(C–O str.), 870(C–Cl str.) cm−1; 1H NMR (400 MHz, DMSO-d6): δ ppm 2.34(s, 6H, 3CH, 3CH), 2.21–2.46(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.90–4.97(dd, J
=
12.6 Hz, 6 Hz, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.18–7.79(m, 3H, ArH), 13.05(s, 1H, SH). 13C NMR (100 MHz, DMSO-d6): δ ppm 26.27(CH2), 28.87(CH2), 85.3(CH), 108.52(CH), 112.98(CH), 116.81(CH), 120.08(CH), 121.91(CH), 124.85(C), 125.71(CH), 129.2(C), 139.69(C), 141.09(C), 155.8(C), 156.41(C), 158.29(C), 173.99(C). MS:m/z = 379 [M]+; Anal. Calcd for C17H12ClF2N3OS: C, 53.76; H, 3.18; N, 11.06. Found: C, 53.69; H, 3.07; N, 10.90%.


## 4.1.9. 5-(6-Fluorochroman-2-yl)-4-(2-methoxyphenyl)-4H-1, 2, 4-triazole-3-thiol (4i)

Yield 90%, mp 251–253°C; IR (DRS): 3075(Ar, C–H str.), 2553(–SH str.), 1581(–C=C–, str.), 1423(H–C–H bend), 1281(C–O str.), 870(C–Cl str.), 1080(C–F str.) cm−1; 1H NMR (400 MHz, DMSO-d6): δ ppm 2.34(s, 6H, 3CH, 3CH), 2.21–2.46(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 3.83(s, 3H, OCH3), 4.90–4.97(dd, J
=
12.6 Hz, 6 Hz, 1H, CH), 6.72–6.95(m, 3H, ArH), 6.99–7.51(m, 4H, ArH), 13.05(s, 1H, SH). 13C NMR (100 MHz, DMSO-d6): δ ppm 26.27(CH2), 28.87(CH2), 56.32(CH3), 85.3(CH), 108.52(CH), 112.98(CH), 115.51(CH), 116.81(CH), 120.83(CH), 123.69(CH), 129.2(C), 131.19(CH), 134.73(C), 139.24(C), 155.8(C), 157.76(C), 158.29(C), 173.54(C). MS:m/z = 357 [M]+; Anal. Calcd for C18H16FN3O2S: C, 60.49; H, 4.51; N, 11.76. Found: C, 60.39; H, 4.29; N, 11.37%.


## 4.1.10. 4-(2, 5-Difluorophenyl)-5-(6-fluorochroman-2-yl)-4H-1,2,4-triazole-3-thiol (4j)

Yield 75%, mp 229–231°C; IR (DRS): 3061(Ar, C–H str.), 2951 (C–H str.), 2535(–SH str.), 1589(–C=C–, str.), 1462(H–C–H bend), 1520(C–O str.), 1075(C–F str.) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 2.34(s, 6H, 3CH, 3CH), 2.21–2.46(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 3.83(s, 3H, OCH3), 4.90–4.97(dd, J
=
12.6 Hz, 6 Hz, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.13–7.22(m, 3H, ArH), 13.05(s, 1H, SH). 13C NMR (100 MHz, CDCl3): 26.27(CH2), 28.87(CH2), 85.3(CH), 108.29(CH), 108.69(CH) 112.98(CH), 116.81(CH), 117.32(CH), 118.79(C), 127.11(CH), 129.2(C), 139.69 (C), 155.8(C), 158.29(C), 159.93(C), 173.54(C). MS:m/z = 363 [M]+; Anal. Calcd for C17H12F3N3O2S: C, 56.19; H, 3.33; N, 11.56. Found: C, 56.06; H, 3.14; N, 11.32%.


## 4.2. General Procedure for the Synthesis of Functionalized 4-Thiazolidinones5a–5j

An equimolar mixture of 6-fluorochroman-2-carbohydrazide2 (0.01 mol) and different aryl aldehydes (0.01 mol) was taken in RBF and to this, thioglycolic acid (mercaptoacetic acid) (0.29 mol) in toluene was added. Then reaction mixture was allowed to reflux in a Dean-Stark assembly with continuous stirring. After completion of the reaction (48 hrs monitoring by TLC), the content was cooled to room temperature and then neutralized with saturated sodium bicarbonate solution. The organic extracts were washed with water and dried over Na2SO4. The solvent was evaporatedin vacuo and the resulting crude product was purified by column chromatography to give the analytical pure compounds5a–5j. Column chromatography was carried out in hexane: ethyl acetate solvent system. Pure compound was eluted in 23% ethyl acetate in hexane.


### 4.2.1. 6-Fluoro-N-(2-(4-methoxyphenyl)-4-oxothiazolidine-3-yl) chroman-2-carboxamide (5a)

Yield 85%, mp 98–100°C; IR (DRS): 3383(Amide–NH str.), 3081(Ar, C–H str.), 2958(C–H str.), 1714(C=O str.), 1688(amide C=O str.), 1542(–NH bend), 1365(C–F str.), 1278(C–O–C str.) cm−1; 1H NMR (400 MHz, DMSO-d6): δ ppm 2.15–2.40(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 3.83(s, 3H, OCH3), 4.69–4.72(d, J
=
16.0 Hz, 1H, CH), 3.91–3.95(d, J
=
15.6 Hz, 1H, CH), 4.69–4.72(dd, J
=
3.6 Hz, 3.2 Hz, 1H, CH), 5.92(s, 1H, CH), 6.72–6.95(m, 3H, ArH), 6.87–7.84(m, 4H, ArH), 8.0(s, 1H, NH), 13C NMR (100 MHz, DMSO-d6): δ ppm 25.25(CH2), 26.19(CH2), 34.2(CH2), 55.33(CH3), 70.50(CH), 85.58(CH), 108.7(CH), 112.44(CH), 114.1(CH), 116.43(CH), 126.91(CH), 129.9(C), 133.68(C), 154.35(C), 157.18 (C), 155.8(C), 158.08(C), 165.35(C), 169.36(C). MS:m/z = 402 [M]+; Anal. Calcd for C20H19FN2O4S: C, 59.69; H, 4.76; N, 6.96. Found: C, 59.23; H, 4.61; N, 6.88%.


### 4.2.2. 6-Fluoro-N-(2-(2-nitrophenyl)-4-oxothiazolidine-3-yl) chroman-2-carboxamide (5b)

Yield 95%, mp 190–192°C; IR (DRS): 3392(Amide–NH str.), 3205(Ar, C–H str.), 1712(C=O str.), 1678(amide C=O str.), 1523(–NH bend), 1590(N=O str.), 1259(C–O–C str.), 1190(C–F str.) cm−1; 1H NMR (400 MHz, DMSO-d6): δ ppm 1.81–2.05(m, 2H, 2CH), 2.61–2.74(m, 2H, 2CH), 3.68–3.72(d, J
=
16.0 Hz, 1H, CH), 3.91–3.95(d, J
=
15.6 Hz, 1H, CH), 4.66–4.69(dd, J
=
3.6 Hz, 3.2 Hz, 1H, CH), 6.12(s, 1H, CH), 6.72–6.79(m, 1H, ArH), 6.84–6.91(m, 2H, ArH), 7.60–7.63(t, 1H, ArH), 7.78–7.87(m, 2H, ArH), 8.04–8.06(d, J
=
8.0 Hz, 1H, ArH), 10.43–10.46(d, J
=
11.6 Hz, 1H, NH). 13C NMR (100 MHz, DMSO-d6): δ ppm 25.25(CH2), 26.19(CH2), 34.2(CH2), 68.3(CH), 85.58(CH), 108.7(CH), 114.1(CH), 116.43(CH), 123.91(CH), 125.5(C), 129.87(CH), 129.9(C), 127.85(CH), 132.06(C), 149.87(C), 154.35(C), 157.18 (C), 169.36(C). MS:m/z = 417 [M]+; Anal. Calcd for C19H16FN3O5S: C, 54.67; H, 3.86; N, 10.07. Found: C, 54.58; H, 3.49; N, 9.99%.


### 4.2.3. 6-Fluoro-N-(2-(4-fluorophenyl)-4-oxothiazolidine-3-yl) chroman-2-carboxamide (5c)

Yield 89%, mp 106–110°C; IR (DRS): 3487(Amide–NH str.), 3041(Ar, C–H str.), 1710(C=O str.), 1676(amide C=O str.), 1537(–NH bend), 1201(C–O–C str.), 1190(C–F str.) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 1.82–2.02(m, 2H, 2CH), 2.56–2.70(m, 2H, 2CH), 3.59–3.78(m, 2H, 2CH), 4.45–4.58(dd, J
=
10.52 Hz, 11.52 Hz, 1H, CH), 5.79–5.83(d, J
=
17.32 Hz, 1H, CH), 6.54–6.72(m, 3H, ArH), 6.86–6.90(t, 1H, ArH), 6.99–7.03(t, 1H, ArH), 7.20–7.22(t, 1H, ArH), 7.33–7.36(t, 1H, ArH), 8.05–8.13(d, J
=
29.44 Hz, 1H, NH). 13C NMR (100 MHz, CDCl3): δ ppm 25.25(CH2), 26.19(CH2), 34.2(CH2), 70.52(CH), 85.58(CH), 108.7(CH), 113.27(CH), 114.1(CH), 116.43(CH), 127.64(CH), 129.9(C), 136.68(C), 154.35(C), 157.18 (C), 160.07(C), 165.35(C), 169.36(C). MS:m/z = 390 [M]+; Anal. Calcd for C19H16F2N2O3S: C, 58.45; H, 4.13; N, 7.18. Found: C, 58.02; H, 4.03; N, 7.10%.


### 4.2.4.N
-(2-(3-Chlorophenyl)-4-oxothiazolidine-3-yl)-6-fluorochroman-2-carboxamide (5d)

Yield 77%, mp 151–153°C; IR (DRS): 3401(Amide–NH str.), 3200(Ar, C–H str.), 1717(C=O str.), 1645(amide C=O str.), 1550(–NH bend), 1245(C–F str.), 1201(C–O–C str.), 820(C–Cl str.) cm−1; 1H NMR (400 MHz, DMSO): δ ppm 2.15–2.40(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.66–4.69(d, J
=
16.0 Hz, 1H, CH), 3.91–3.95(d, J
=
15.6 Hz, 1H, CH), 4.69–4.72(dd, J
=
3.6 Hz, 3.2 Hz, 1H, CH), 5.92(s, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.24–7.43(m, 4H, ArH), 8.0(s, 1H, NH). 13C NMR (100 MHz, CDCl3): δ ppm 25.25(CH2), 26.19(CH2), 34.2(CH2), 71.78(CH), 85.58(CH), 108.7(CH), 114.1(CH), 116.43(CH), 124.5(CH), 124.93(CH), 126.41(CH), 128(CH), 132.25(C), 140.45(C), 145.35(C), 157.18 (C), 165.35(C), 169.36(C). MS:m/z = 406 [M]+; Anal. Calcd for C19H16ClFN2O3S: C, 56.09; H, 3.96; N, 6.89. Found: C, 55.90; H, 3.83; N, 6.83%.


### 4.2.5.N-(2-(4-Bromophenyl)-4-oxothiazolidine-3-yl)-6-fluorochroman-2-carboxamide (5e)

Yield 90%, mp 118–120°C; IR (DRS): 3452(Amide–NH str.), 3000(Ar, C–H str.), 1725(C=O str.), 1640(amide C=O str.), 1545(–NH bend), 1345(C–F str.), 1251(C–O–C str.), 520(C–Br str.) cm−1; 1H NMR (400 MHz, DMSO-d6): δ ppm 2.15–2.40(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.63–4.66(d, J
=
16.0 Hz, 1H, CH), 3.91–3.95(d, J
=
15.6 Hz, 1H, CH), 4.63–4.66(dd, J
=
3.6 Hz, 3.2 Hz, 1H, CH), 5.92(s, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.12–7.85(m, 4H, ArH), 8.0(s, 1H, NH). 13C NMR (100 MHz, DMSO-d6): δ ppm 25.25(CH2), 26.19(CH2), 34.2(CH2), 70.50(CH), 85.58(CH), 108.7(CH), 114.1(CH), 116.43(CH), 120.41(C), 126.7(CH), 129.36(CH), 129.9(C), 138.93(C), 154.35(C), 157.18 (C), 165.35(C), 169.36(C). MS:m/z = 452 [M+1]+; Anal. Calcd for C19H16BrFN2O3S: C, 50.56; H, 3.57; N, 6.21. Found: C, 50.45; H, 3.28; N, 6.11%.


### 4.2.6. 6-Fluoro-N-(2-(4-hydroxyphenyl)-4-oxothiazolidine-3-yl) chroman-2-carboxamide (5f)

Yield 73%, mp 132–134°C; IR (DRS): 3452(Amide–NH str.), (–OH, broad), 3011(Ar, C–H str.), 1728(C=O str.), 1645(amide C=O str.), 1545(–NH bend), 1352(C–F str.), 1278(C–O–C str.) cm−1; 1H NMR (400 MHz, DMSO-d6): δ ppm 2.15–2.40(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.63–4.66(d, J
=
16.0 Hz, 1H, CH), 3.91–3.95(d, J
=
15.6 Hz, 1H, CH), 4.63–4.66(dd, J
=
3.6 Hz, 3.2 Hz, 1H, CH), 5.35(s, 1H, OH), 5.92(s, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.14–7.86(m, 4H, ArH), 8.0(s, 1H, NH). 13C NMR (100 MHz, DMSO-d6): δ ppm 25.25(CH2), 26.19(CH2), 34.2(CH2), 55.33(CH3), 70.50(CH), 85.58(CH), 108.7(CH), 114.1(CH), 116.43(CH), 116.68(C), 125.81(CH), 129.9(C), 132.68(C), 154.35(C), 157.46 (C), 157.18(C), 165.35(C), 169.36(C). MS:m/z = 388 [M]+; Anal. Calcd for C19H17FN2O4S: C, 58.75; H, 4.41; N, 7.21. Found: C, 58.56; H, 4.34; N, 7.06%.


### 4.2.7. 6-Fluoro-N-(4-oxo-2-(p-tolyl) thiazolidin-3-yl) chroman-2-carboxamide (5g)

Yield 84%, mp 89–91°C; IR (DRS): 3328(Amide–NH str.), 2998(Ar, C–H str.), 2900(C–H str.), 1741(C=O str.), 1652(amide C=O str.), 1548(–NH bend), 1371(C–F str.), 1300(C–O–C str.) cm−1; 1H NMR (400 MHz, DMSO-d6): δ ppm 2.15–2.32(m, 2H, 2CH), 2.34(s, 3H, 3CH), 2.75–2.85(m, 2H, 2CH), 4.63–4.66(d, J
=
16.0 Hz, 1H, CH), 3.91–3.95(d, J
=
15.6 Hz, 1H, CH), 4.63–4.66(dd, J
=
3.6 Hz, 3.2 Hz, 1H, CH), 5.92(s, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.11(m, 4H, ArH), 8.0(s, 1H, NH). 13C NMR (100 MHz, DMSO-d6): δ ppm 21.03(CH3), 25.25(CH2), 26.19(CH2), 34.2(CH2), 70.50(CH), 85.58(CH), 108.7(CH), 114.1(CH), 116.43(CH), 126.73(CH), 127.98(CH), 129.9(C), 136.48(C), 136.52(C), 154.35(C), 157.18(C), 165.35(C), 169.36(C). MS:m/z = 386 [M]+; Anal. Calcd C20H19FN2O3S: C, 62.16; H, 4.96; N, 7.25. Found: C, 62.07; H, 4.55; N, 7.09%.


### 4.2.8.N-(2-(2-Chlorophenyl)-4-oxothiazolidine-3-yl)-6-fluorochroman-2-carboxamide (5h)

Yield 71%, mp 158–160°C; IR (DRS): 3412(Amide–NH str.), 3212(Ar, C–H str.), 1725(C=O str.), 1685(amide C=O str.), 1558(–NH bend), 1251(C–F str.), 1228(C–O–C str.), 800(C–Cl str.), 770(o-di substituted) cm−1; 1H NMR (400 MHz, DMSO): δ ppm 2.15–2.32(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.63–4.66(d, J
=
16.0 Hz, 1H, CH), 3.91–3.95(d, J
=
15.6 Hz, 1H, CH), 4.63–4.66(dd, J
=
3.6 Hz, 3.2 Hz, 1H, CH), 5.92(s, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.17–7.65(m, 4H, ArH), 8.0(s, 1H, NH). 13C NMR (100 MHz, CDCl3): δ ppm 25.25(CH2), 26.19(CH2), 34.2(CH2), 67.50(CH), 85.58(CH), 108.7(CH), 114.1(CH), 116.43(CH), 125.18(CH), 125.89(CH), 127.02(CH), 127.26(CH), 129.9(C), 131.68(C), 133.39(C), 154.35(C), 157.18 (C), 165.35(C), 169.36(C). MS:m/z = 406 [M]+; Anal. Calcd for C19H16ClFN2O3S: C, 56.09; H, 3.96; N, 6.89. Found: C, 55.93; H, 3.77; N, 6.84%.


### 4.2.9. 6-Fluoro-N-(2-(4-nitrophenyl)-4-oxothiazolidine-3-yl) chroman-2-carboxamide (5i)

Yield 79%, mp 207–209°C; IR (DRS): 3398(Amide–NH str.), 3212(Ar, C–H str.), 1728(C=O str.), 1688(amide C=O str.), 1543(–NH bend), 1595(N=O str.), 1272(C–O–C str.), 1290(C–F str.) 790(p-di substituted) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 2.15–2.32(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.63–4.66(d, J
=
16.0 Hz, 1H, CH), 3.91–3.95(d, J
=
15.6 Hz, 1H, CH), 4.63–4.66(dd, J
=
3.6 Hz, 3.2 Hz, 1H, CH), 5.92(s, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.49–8.14(m, 4H, ArH), 8.0(s, 1H, NH). 13C NMR (100 MHz, CDCl3): δ ppm 25.25(CH2), 26.19(CH2), 34.2(CH2), 70.52(CH), 85.58(CH), 108.7(CH), 114.1(CH), 116.43(CH), 122.91(CH), 126.32(CH), 129.9(C), 144.08(C), 145.35(C), 154.35 (C), 157.18(C), 165.35(C), 169.36(C). MS:m/z = 417 [M]+; Anal. Calcd for C17H14FN3O2: C, 54.67; H, 3.86; N, 10.07. Found: C, 54.39; H, 3.79; N, 9.89%.


### 4.2.10.N-(2-(3-Bromophenyl)-4-oxothiazolidine-3-yl)-6-fluorochroman-2-carboxamide (5j)

Yield 88%, mp 166–168°C; IR (DRS): 3482(Amide–NH str.), 3110(Ar, C–H str.), 1745(C=O str.), 1590(amide C=O str.), 1485(–NH bend), 1354(C–F str.), 1281(C–O–C str.), 680(m-di substituted), 520(C–Br str.) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 2.15–2.32(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.63–4.66(d, J
=
16.0 Hz, 1H, CH), 3.91–3.95(d, J
=
15.6 Hz, 1H, CH), 4.63–4.66(dd, J
=
3.6 Hz, 3.2 Hz, 1H, CH), 5.92(s, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.22–7.41(m, 4H, ArH), 8.0(s, 1H, NH). 13C NMR (100 MHz, CDCl3): δ ppm 25.25(CH2), 26.19(CH2), 34.2(CH2), 70.32(CH), 85.58(CH), 108.7(CH), 114.1(CH), 116.43(CH), 120.91(C), 127.55(CH), 127.95(CH), 128.17(CH), 128.74(CH), 129.9(C), 140.65(C), 154.35(C), 157.18 (C), 165.35(C), 169.36(C).MS:m/z = 452 [M+1] +; Anal. Calcd for C19H16FN3O5S: C, 50.56; H, 3.57; N, 6.21. Found: C, 50.17; H, 3.14; N, 6.12%.


## 4.2.1. 6-Fluoro-N-(2-(4-methoxyphenyl)-4-oxothiazolidine-3-yl) chroman-2-carboxamide (5a)

Yield 85%, mp 98–100°C; IR (DRS): 3383(Amide–NH str.), 3081(Ar, C–H str.), 2958(C–H str.), 1714(C=O str.), 1688(amide C=O str.), 1542(–NH bend), 1365(C–F str.), 1278(C–O–C str.) cm−1; 1H NMR (400 MHz, DMSO-d6): δ ppm 2.15–2.40(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 3.83(s, 3H, OCH3), 4.69–4.72(d, J
=
16.0 Hz, 1H, CH), 3.91–3.95(d, J
=
15.6 Hz, 1H, CH), 4.69–4.72(dd, J
=
3.6 Hz, 3.2 Hz, 1H, CH), 5.92(s, 1H, CH), 6.72–6.95(m, 3H, ArH), 6.87–7.84(m, 4H, ArH), 8.0(s, 1H, NH), 13C NMR (100 MHz, DMSO-d6): δ ppm 25.25(CH2), 26.19(CH2), 34.2(CH2), 55.33(CH3), 70.50(CH), 85.58(CH), 108.7(CH), 112.44(CH), 114.1(CH), 116.43(CH), 126.91(CH), 129.9(C), 133.68(C), 154.35(C), 157.18 (C), 155.8(C), 158.08(C), 165.35(C), 169.36(C). MS:m/z = 402 [M]+; Anal. Calcd for C20H19FN2O4S: C, 59.69; H, 4.76; N, 6.96. Found: C, 59.23; H, 4.61; N, 6.88%.


## 4.2.2. 6-Fluoro-N-(2-(2-nitrophenyl)-4-oxothiazolidine-3-yl) chroman-2-carboxamide (5b)

Yield 95%, mp 190–192°C; IR (DRS): 3392(Amide–NH str.), 3205(Ar, C–H str.), 1712(C=O str.), 1678(amide C=O str.), 1523(–NH bend), 1590(N=O str.), 1259(C–O–C str.), 1190(C–F str.) cm−1; 1H NMR (400 MHz, DMSO-d6): δ ppm 1.81–2.05(m, 2H, 2CH), 2.61–2.74(m, 2H, 2CH), 3.68–3.72(d, J
=
16.0 Hz, 1H, CH), 3.91–3.95(d, J
=
15.6 Hz, 1H, CH), 4.66–4.69(dd, J
=
3.6 Hz, 3.2 Hz, 1H, CH), 6.12(s, 1H, CH), 6.72–6.79(m, 1H, ArH), 6.84–6.91(m, 2H, ArH), 7.60–7.63(t, 1H, ArH), 7.78–7.87(m, 2H, ArH), 8.04–8.06(d, J
=
8.0 Hz, 1H, ArH), 10.43–10.46(d, J
=
11.6 Hz, 1H, NH). 13C NMR (100 MHz, DMSO-d6): δ ppm 25.25(CH2), 26.19(CH2), 34.2(CH2), 68.3(CH), 85.58(CH), 108.7(CH), 114.1(CH), 116.43(CH), 123.91(CH), 125.5(C), 129.87(CH), 129.9(C), 127.85(CH), 132.06(C), 149.87(C), 154.35(C), 157.18 (C), 169.36(C). MS:m/z = 417 [M]+; Anal. Calcd for C19H16FN3O5S: C, 54.67; H, 3.86; N, 10.07. Found: C, 54.58; H, 3.49; N, 9.99%.


## 4.2.3. 6-Fluoro-N-(2-(4-fluorophenyl)-4-oxothiazolidine-3-yl) chroman-2-carboxamide (5c)

Yield 89%, mp 106–110°C; IR (DRS): 3487(Amide–NH str.), 3041(Ar, C–H str.), 1710(C=O str.), 1676(amide C=O str.), 1537(–NH bend), 1201(C–O–C str.), 1190(C–F str.) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 1.82–2.02(m, 2H, 2CH), 2.56–2.70(m, 2H, 2CH), 3.59–3.78(m, 2H, 2CH), 4.45–4.58(dd, J
=
10.52 Hz, 11.52 Hz, 1H, CH), 5.79–5.83(d, J
=
17.32 Hz, 1H, CH), 6.54–6.72(m, 3H, ArH), 6.86–6.90(t, 1H, ArH), 6.99–7.03(t, 1H, ArH), 7.20–7.22(t, 1H, ArH), 7.33–7.36(t, 1H, ArH), 8.05–8.13(d, J
=
29.44 Hz, 1H, NH). 13C NMR (100 MHz, CDCl3): δ ppm 25.25(CH2), 26.19(CH2), 34.2(CH2), 70.52(CH), 85.58(CH), 108.7(CH), 113.27(CH), 114.1(CH), 116.43(CH), 127.64(CH), 129.9(C), 136.68(C), 154.35(C), 157.18 (C), 160.07(C), 165.35(C), 169.36(C). MS:m/z = 390 [M]+; Anal. Calcd for C19H16F2N2O3S: C, 58.45; H, 4.13; N, 7.18. Found: C, 58.02; H, 4.03; N, 7.10%.


## 4.2.4.N
-(2-(3-Chlorophenyl)-4-oxothiazolidine-3-yl)-6-fluorochroman-2-carboxamide (5d)

Yield 77%, mp 151–153°C; IR (DRS): 3401(Amide–NH str.), 3200(Ar, C–H str.), 1717(C=O str.), 1645(amide C=O str.), 1550(–NH bend), 1245(C–F str.), 1201(C–O–C str.), 820(C–Cl str.) cm−1; 1H NMR (400 MHz, DMSO): δ ppm 2.15–2.40(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.66–4.69(d, J
=
16.0 Hz, 1H, CH), 3.91–3.95(d, J
=
15.6 Hz, 1H, CH), 4.69–4.72(dd, J
=
3.6 Hz, 3.2 Hz, 1H, CH), 5.92(s, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.24–7.43(m, 4H, ArH), 8.0(s, 1H, NH). 13C NMR (100 MHz, CDCl3): δ ppm 25.25(CH2), 26.19(CH2), 34.2(CH2), 71.78(CH), 85.58(CH), 108.7(CH), 114.1(CH), 116.43(CH), 124.5(CH), 124.93(CH), 126.41(CH), 128(CH), 132.25(C), 140.45(C), 145.35(C), 157.18 (C), 165.35(C), 169.36(C). MS:m/z = 406 [M]+; Anal. Calcd for C19H16ClFN2O3S: C, 56.09; H, 3.96; N, 6.89. Found: C, 55.90; H, 3.83; N, 6.83%.


## 4.2.5.N-(2-(4-Bromophenyl)-4-oxothiazolidine-3-yl)-6-fluorochroman-2-carboxamide (5e)

Yield 90%, mp 118–120°C; IR (DRS): 3452(Amide–NH str.), 3000(Ar, C–H str.), 1725(C=O str.), 1640(amide C=O str.), 1545(–NH bend), 1345(C–F str.), 1251(C–O–C str.), 520(C–Br str.) cm−1; 1H NMR (400 MHz, DMSO-d6): δ ppm 2.15–2.40(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.63–4.66(d, J
=
16.0 Hz, 1H, CH), 3.91–3.95(d, J
=
15.6 Hz, 1H, CH), 4.63–4.66(dd, J
=
3.6 Hz, 3.2 Hz, 1H, CH), 5.92(s, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.12–7.85(m, 4H, ArH), 8.0(s, 1H, NH). 13C NMR (100 MHz, DMSO-d6): δ ppm 25.25(CH2), 26.19(CH2), 34.2(CH2), 70.50(CH), 85.58(CH), 108.7(CH), 114.1(CH), 116.43(CH), 120.41(C), 126.7(CH), 129.36(CH), 129.9(C), 138.93(C), 154.35(C), 157.18 (C), 165.35(C), 169.36(C). MS:m/z = 452 [M+1]+; Anal. Calcd for C19H16BrFN2O3S: C, 50.56; H, 3.57; N, 6.21. Found: C, 50.45; H, 3.28; N, 6.11%.


## 4.2.6. 6-Fluoro-N-(2-(4-hydroxyphenyl)-4-oxothiazolidine-3-yl) chroman-2-carboxamide (5f)

Yield 73%, mp 132–134°C; IR (DRS): 3452(Amide–NH str.), (–OH, broad), 3011(Ar, C–H str.), 1728(C=O str.), 1645(amide C=O str.), 1545(–NH bend), 1352(C–F str.), 1278(C–O–C str.) cm−1; 1H NMR (400 MHz, DMSO-d6): δ ppm 2.15–2.40(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.63–4.66(d, J
=
16.0 Hz, 1H, CH), 3.91–3.95(d, J
=
15.6 Hz, 1H, CH), 4.63–4.66(dd, J
=
3.6 Hz, 3.2 Hz, 1H, CH), 5.35(s, 1H, OH), 5.92(s, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.14–7.86(m, 4H, ArH), 8.0(s, 1H, NH). 13C NMR (100 MHz, DMSO-d6): δ ppm 25.25(CH2), 26.19(CH2), 34.2(CH2), 55.33(CH3), 70.50(CH), 85.58(CH), 108.7(CH), 114.1(CH), 116.43(CH), 116.68(C), 125.81(CH), 129.9(C), 132.68(C), 154.35(C), 157.46 (C), 157.18(C), 165.35(C), 169.36(C). MS:m/z = 388 [M]+; Anal. Calcd for C19H17FN2O4S: C, 58.75; H, 4.41; N, 7.21. Found: C, 58.56; H, 4.34; N, 7.06%.


## 4.2.7. 6-Fluoro-N-(4-oxo-2-(p-tolyl) thiazolidin-3-yl) chroman-2-carboxamide (5g)

Yield 84%, mp 89–91°C; IR (DRS): 3328(Amide–NH str.), 2998(Ar, C–H str.), 2900(C–H str.), 1741(C=O str.), 1652(amide C=O str.), 1548(–NH bend), 1371(C–F str.), 1300(C–O–C str.) cm−1; 1H NMR (400 MHz, DMSO-d6): δ ppm 2.15–2.32(m, 2H, 2CH), 2.34(s, 3H, 3CH), 2.75–2.85(m, 2H, 2CH), 4.63–4.66(d, J
=
16.0 Hz, 1H, CH), 3.91–3.95(d, J
=
15.6 Hz, 1H, CH), 4.63–4.66(dd, J
=
3.6 Hz, 3.2 Hz, 1H, CH), 5.92(s, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.11(m, 4H, ArH), 8.0(s, 1H, NH). 13C NMR (100 MHz, DMSO-d6): δ ppm 21.03(CH3), 25.25(CH2), 26.19(CH2), 34.2(CH2), 70.50(CH), 85.58(CH), 108.7(CH), 114.1(CH), 116.43(CH), 126.73(CH), 127.98(CH), 129.9(C), 136.48(C), 136.52(C), 154.35(C), 157.18(C), 165.35(C), 169.36(C). MS:m/z = 386 [M]+; Anal. Calcd C20H19FN2O3S: C, 62.16; H, 4.96; N, 7.25. Found: C, 62.07; H, 4.55; N, 7.09%.


## 4.2.8.N-(2-(2-Chlorophenyl)-4-oxothiazolidine-3-yl)-6-fluorochroman-2-carboxamide (5h)

Yield 71%, mp 158–160°C; IR (DRS): 3412(Amide–NH str.), 3212(Ar, C–H str.), 1725(C=O str.), 1685(amide C=O str.), 1558(–NH bend), 1251(C–F str.), 1228(C–O–C str.), 800(C–Cl str.), 770(o-di substituted) cm−1; 1H NMR (400 MHz, DMSO): δ ppm 2.15–2.32(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.63–4.66(d, J
=
16.0 Hz, 1H, CH), 3.91–3.95(d, J
=
15.6 Hz, 1H, CH), 4.63–4.66(dd, J
=
3.6 Hz, 3.2 Hz, 1H, CH), 5.92(s, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.17–7.65(m, 4H, ArH), 8.0(s, 1H, NH). 13C NMR (100 MHz, CDCl3): δ ppm 25.25(CH2), 26.19(CH2), 34.2(CH2), 67.50(CH), 85.58(CH), 108.7(CH), 114.1(CH), 116.43(CH), 125.18(CH), 125.89(CH), 127.02(CH), 127.26(CH), 129.9(C), 131.68(C), 133.39(C), 154.35(C), 157.18 (C), 165.35(C), 169.36(C). MS:m/z = 406 [M]+; Anal. Calcd for C19H16ClFN2O3S: C, 56.09; H, 3.96; N, 6.89. Found: C, 55.93; H, 3.77; N, 6.84%.


## 4.2.9. 6-Fluoro-N-(2-(4-nitrophenyl)-4-oxothiazolidine-3-yl) chroman-2-carboxamide (5i)

Yield 79%, mp 207–209°C; IR (DRS): 3398(Amide–NH str.), 3212(Ar, C–H str.), 1728(C=O str.), 1688(amide C=O str.), 1543(–NH bend), 1595(N=O str.), 1272(C–O–C str.), 1290(C–F str.) 790(p-di substituted) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 2.15–2.32(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.63–4.66(d, J
=
16.0 Hz, 1H, CH), 3.91–3.95(d, J
=
15.6 Hz, 1H, CH), 4.63–4.66(dd, J
=
3.6 Hz, 3.2 Hz, 1H, CH), 5.92(s, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.49–8.14(m, 4H, ArH), 8.0(s, 1H, NH). 13C NMR (100 MHz, CDCl3): δ ppm 25.25(CH2), 26.19(CH2), 34.2(CH2), 70.52(CH), 85.58(CH), 108.7(CH), 114.1(CH), 116.43(CH), 122.91(CH), 126.32(CH), 129.9(C), 144.08(C), 145.35(C), 154.35 (C), 157.18(C), 165.35(C), 169.36(C). MS:m/z = 417 [M]+; Anal. Calcd for C17H14FN3O2: C, 54.67; H, 3.86; N, 10.07. Found: C, 54.39; H, 3.79; N, 9.89%.


## 4.2.10.N-(2-(3-Bromophenyl)-4-oxothiazolidine-3-yl)-6-fluorochroman-2-carboxamide (5j)

Yield 88%, mp 166–168°C; IR (DRS): 3482(Amide–NH str.), 3110(Ar, C–H str.), 1745(C=O str.), 1590(amide C=O str.), 1485(–NH bend), 1354(C–F str.), 1281(C–O–C str.), 680(m-di substituted), 520(C–Br str.) cm−1; 1H NMR (400 MHz, CDCl3): δ ppm 2.15–2.32(m, 2H, 2CH), 2.75–2.85(m, 2H, 2CH), 4.63–4.66(d, J
=
16.0 Hz, 1H, CH), 3.91–3.95(d, J
=
15.6 Hz, 1H, CH), 4.63–4.66(dd, J
=
3.6 Hz, 3.2 Hz, 1H, CH), 5.92(s, 1H, CH), 6.72–6.95(m, 3H, ArH), 7.22–7.41(m, 4H, ArH), 8.0(s, 1H, NH). 13C NMR (100 MHz, CDCl3): δ ppm 25.25(CH2), 26.19(CH2), 34.2(CH2), 70.32(CH), 85.58(CH), 108.7(CH), 114.1(CH), 116.43(CH), 120.91(C), 127.55(CH), 127.95(CH), 128.17(CH), 128.74(CH), 129.9(C), 140.65(C), 154.35(C), 157.18 (C), 165.35(C), 169.36(C).MS:m/z = 452 [M+1] +; Anal. Calcd for C19H16FN3O5S: C, 50.56; H, 3.57; N, 6.21. Found: C, 50.17; H, 3.14; N, 6.12%.



---

*Source: 186207-2014-10-30.xml*